MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma - PubMed (original) (raw)
. 2012 Jun;55(6):1852-62.
doi: 10.1002/hep.25576.
Affiliations
- PMID: 22234835
- DOI: 10.1002/hep.25576
MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma
YuXiang Fang et al. Hepatology. 2012 Jun.
Erratum in
- Hepatology. 2014 Mar;59(3):1216
Abstract
MicroRNAs (miRNAs) are known to be involved in carcinogenesis and tumor progression in hepatocellular carcinoma (HCC). Recently, microRNA-7 (miR-7) has been proven to play a substantial role in glioblastoma and breast cancer, but its functions in the context of HCC remain unknown. Here, we demonstrate that miR-7 inhibits HCC cell growth and metastasis in vitro and in vivo. We first screened and identified a novel miR-7 target, phosphoinositide 3-kinase catalytic subunit delta (PIK3CD). Overexpression of miR-7 would specifically and markedly down-regulate its expression. miR-7-overexpressing subclones showed significant cell growth inhibition by G(0) /G(1) -phase cell-cycle arrest and significant impairment of cell migration in vitro. To identify the mechanisms, we investigated the phosphoinositide 3-kinase (PI3K)/Akt pathway and found that Akt, mammalian target of rapamycin (mTOR), and p70S6K were down-regulated, whereas 4EBP1 was up-regulated in miR-7-overexpressing subclones. We also identified two novel, putative miR-7 target genes, mTOR and p70S6K, which further suggests that miR-7 may be a key regulator of the PI3K/Akt pathway. In xenograft animal experiments, we found that overexpressed miR-7 effectively repressed tumor growth (3.5-fold decrease in mean tumor volume; n = 5) and abolished extrahepatic migration from liver to lung in a nude mouse model of metastasis (n = 5). The number of visible nodules on the lung surface was reduced by 32-fold. A correlation between miR-7 and PIK3CD expression was also confirmed in clinical samples of HCC.
Conclusion: These findings indicate that miR-7 functions as a tumor suppressor and plays a substantial role in inhibiting the tumorigenesis and reversing the metastasis of HCC through the PI3K/Akt/mTOR-signaling pathway in vitro and in vivo. By targeting PIK3CD, mTOR, and p70S6K, miR-7 efficiently regulates the PI3K/Akt pathway. Given these results, miR-7 may be a potential therapeutic or diagnostic/prognostic target for treating HCC.
Copyright © 2012 American Association for the Study of Liver Diseases.
Similar articles
- MiR-124 suppresses cell proliferation in hepatocellular carcinoma by targeting PIK3CA.
Lang Q, Ling C. Lang Q, et al. Biochem Biophys Res Commun. 2012 Sep 21;426(2):247-52. doi: 10.1016/j.bbrc.2012.08.075. Epub 2012 Aug 23. Biochem Biophys Res Commun. 2012. PMID: 22940133 - MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
Xia H, Ooi LL, Hui KM. Xia H, et al. Hepatology. 2013 Aug;58(2):629-41. doi: 10.1002/hep.26369. Epub 2013 Jun 25. Hepatology. 2013. PMID: 23471579 - MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma.
Chen JS, Li HS, Huang JQ, Dong SH, Huang ZJ, Yi W, Zhan GF, Feng JT, Sun JC, Huang XH. Chen JS, et al. Cancer Lett. 2016 May 28;375(1):73-83. doi: 10.1016/j.canlet.2016.02.043. Epub 2016 Mar 2. Cancer Lett. 2016. PMID: 26944318 - [EEF1A2 inhibits the p53 function in hepatocellular carcinoma via PI3K/AKT/mTOR-dependent stabilization of MDM4].
Longerich T. Longerich T. Pathologe. 2014 Nov;35 Suppl 2:177-84. doi: 10.1007/s00292-014-2007-y. Pathologe. 2014. PMID: 25394965 Review. German. - Role of regulatory miRNAs of the PI3K/AKT/mTOR signaling in the pathogenesis of hepatocellular carcinoma.
Rahmani F, Ziaeemehr A, Shahidsales S, Gharib M, Khazaei M, Ferns GA, Ryzhikov M, Avan A, Hassanian SM. Rahmani F, et al. J Cell Physiol. 2020 May;235(5):4146-4152. doi: 10.1002/jcp.29333. Epub 2019 Oct 29. J Cell Physiol. 2020. PMID: 31663122 Review.
Cited by
- Autophagy-associated biomarkers ULK2, UVRAG, and miRNAs miR-21, miR-126, and miR-374: Prognostic significance in glioma patients.
Amin W, Enam SA, Sufiyan S, Ghias K, Bajwa MH, Ilyas S, Laghari AA, Naeem S, Abidi SH, Mughal N. Amin W, et al. PLoS One. 2024 Sep 30;19(9):e0311308. doi: 10.1371/journal.pone.0311308. eCollection 2024. PLoS One. 2024. PMID: 39348350 Free PMC article. - NUP37 accumulation mediated by TRIM28 enhances lipid synthesis to accelerate HCC progression.
Liu Z, Hu Q, Luo Q, Zhang G, Yang W, Cao K, Fang R, Wang R, Shi H, Zhang B. Liu Z, et al. Oncogene. 2024 Sep 18. doi: 10.1038/s41388-024-03167-1. Online ahead of print. Oncogene. 2024. PMID: 39294431 - MicroRNA as Key Players in Hepatocellular Carcinoma: Insights into Their Role in Metastasis.
Saadh MJ, Hussain QM, Alazzawi TS, Fahdil AA, Athab ZH, Yarmukhamedov B, Al-Nuaimi AMA, Alsaikhan F, Farhood B. Saadh MJ, et al. Biochem Genet. 2024 Aug 5. doi: 10.1007/s10528-024-10897-0. Online ahead of print. Biochem Genet. 2024. PMID: 39103713 Review. - miR-449a: A Promising Biomarker and Therapeutic Target in Cancer and Other Diseases.
Barati T, Mirzaei Z, Ebrahimi A, Shekari Khaniani M, Mansoori Derakhshan S. Barati T, et al. Cell Biochem Biophys. 2024 Sep;82(3):1629-1650. doi: 10.1007/s12013-024-01322-9. Epub 2024 May 29. Cell Biochem Biophys. 2024. PMID: 38809350 Review. - Pancreatic cancer cells hijack tumor suppressive microRNA-26a to promote radioresistance and potentiate tumor repopulation.
Jiang MJ, Lin CJ, Liu FR, Mei Z, Gu DN, Tian L. Jiang MJ, et al. Heliyon. 2024 May 15;10(10):e31346. doi: 10.1016/j.heliyon.2024.e31346. eCollection 2024 May 30. Heliyon. 2024. PMID: 38807872 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous